Gene ID ▼ | Gene Name | Gene Symbol | Disease Ontology |
---|---|---|---|
108929368 | heparan sulfate-glucosamine 3-sulfotransferase 5 |
|
|
108929252 | alpha-(1,3)-fucosyltransferase 9-like |
|
|
108929240 | alpha-(1,3)-fucosyltransferase 9-like |
|
|
108929150 | alpha-(1,3)-fucosyltransferase 9-like |
|
|
108929052 | LARGE xylosyl- and glucuronyltransferase 2-like |
|
|
108929023 | polypeptide N-acetylgalactosaminyltransferase 13-like |
|
|
108929022 | UDP-glucuronosyltransferase-like |
|
|
108929011 | UDP-glucuronosyltransferase 1-6-like |
|
|
108928905 | chondroitin polymerizing factor |
|
|
108928892 | protein O-fucosyltransferase 2 |
|
|
108928829 | beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
|
|
108928631 | potassium channel, subfamily K, member 6 |
|
|
108928630 | dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) |
|
|
108928562 | exostosin-1-like |
|
|
108928549 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
|
|
108928540 | heparan-sulfate 6-O-sulfotransferase 3-B |
|
|
108928533 | UDP-glucose glycoprotein glucosyltransferase 2 |
|
|
108928190 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like |
|
|
108928068 | purinergic receptor P2X, ligand-gated ion channel, 1 |
|
|
108927963 | polypeptide N-acetylgalactosaminyltransferase 13 |
|
|
108927941 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
|
|
108927916 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1b |
|
|
108927889 | chondroitin sulfate synthase 2-like |
|
|
108927880 | polypeptide N-acetylgalactosaminyltransferase 5 |
|
|
108927818 | beta-1,4-galactosyltransferase 1-like |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024